• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名新冠肺炎患者出现复杂性阑尾炎、急性胰腺炎、胸腔积液和窦性心动过缓。

Complicated appendicitis, acute pancreatitis, pleural effusion, and sinus bradycardia in a COVID-19 patient.

作者信息

Hatami Danial, Alavi Seyed Mohamamd Amin

机构信息

Faculty of Medicine Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.

出版信息

Clin Case Rep. 2023 Mar 8;11(3):e7077. doi: 10.1002/ccr3.7077. eCollection 2023 Mar.

DOI:10.1002/ccr3.7077
PMID:36911648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995805/
Abstract

This study shows that complicated appendicitis and acute pancreatitis could occur during a COVID-19 infection, since the same gastrointestinal manifestations are notable in all aforementioned diseases. Sinus bradycardia is a side effect of remdesivir. Both COVID-19 infection and remdesivir therapy can elevate liver transaminases.

摘要

这项研究表明，在新型冠状病毒肺炎（COVID-19）感染期间可能会发生复杂性阑尾炎和急性胰腺炎，因为在上述所有疾病中，相同的胃肠道表现都很明显。窦性心动过缓是瑞德西韦的副作用。新型冠状病毒肺炎感染和瑞德西韦治疗均可使肝转氨酶升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f9/9995805/3b2fd44a9f58/CCR3-11-e7077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f9/9995805/3b7845f652d3/CCR3-11-e7077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f9/9995805/3b2fd44a9f58/CCR3-11-e7077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f9/9995805/3b7845f652d3/CCR3-11-e7077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6f9/9995805/3b2fd44a9f58/CCR3-11-e7077-g001.jpg

相似文献

1
Complicated appendicitis, acute pancreatitis, pleural effusion, and sinus bradycardia in a COVID-19 patient.一名新冠肺炎患者出现复杂性阑尾炎、急性胰腺炎、胸腔积液和窦性心动过缓。
Clin Case Rep. 2023 Mar 8;11(3):e7077. doi: 10.1002/ccr3.7077. eCollection 2023 Mar.
2
Correction to "Complicated appendicitis, acute pancreatitis, pleural effusion, and sinus bradycardia in a COVID-19 patient".对“一名COVID-19患者的复杂性阑尾炎、急性胰腺炎、胸腔积液和窦性心动过缓”的勘误
Clin Case Rep. 2023 Nov 13;11(11):e8196. doi: 10.1002/ccr3.8196. eCollection 2023 Nov.
3
Erratum:  Correction to "Complicated appendicitis, acute pancreatitis, pleural effusion, and sinus bradycardia in a COVID-19 patient".勘误：对“一名新冠肺炎患者并发阑尾炎、急性胰腺炎、胸腔积液和窦性心动过缓”的更正。
Clin Case Rep. 2023 Sep 25;11(9):e7493. doi: 10.1002/ccr3.7493. eCollection 2023 Sep.
4
Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.瑞德西韦在新冠病毒疾病中引发显著窦性心动过缓
Cureus. 2022 Jul 25;14(7):e27249. doi: 10.7759/cureus.27249. eCollection 2022 Jul.
5
Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.瑞德西韦治疗儿童急性 2019 冠状病毒病合并窦性心动过缓：病例报告及文献复习。
J Pediatric Infect Dis Soc. 2021 Oct 27;10(9):926-929. doi: 10.1093/jpids/piab029.
6
Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.瑞德西韦与新型冠状病毒肺炎患者窦性心动过缓的相关性：一项前瞻性纵向研究。
Front Pharmacol. 2023 Jan 17;13:1107198. doi: 10.3389/fphar.2022.1107198. eCollection 2022.
7
Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.瑞德西韦引起的 COVID-19 年轻患者心动过缓：病例报告。
Infection. 2022 Dec;50(6):1605-1613. doi: 10.1007/s15010-022-01854-3. Epub 2022 Jun 14.
8
A Case of Multisystem Inflammatory Syndrome in Children Presenting as Acute Appendicitis and Pancreatitis.儿童多系统炎症综合征病例报告，表现为急性阑尾炎和胰腺炎。
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2021 Oct 26;42(2):95-101. doi: 10.2478/prilozi-2021-0027.
9
Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19.瑞德西韦导致新型冠状病毒肺炎患者出现严重窦性心动过缓
Cureus. 2022 Jul 26;14(7):e27307. doi: 10.7759/cureus.27307. eCollection 2022 Jul.
10
Bradyarrhythmia After Remdesivir Administration in SARS-CoV-2: A Review of Literature and Meta-Analysis of Observational Studies in Epidemiology.瑞德西韦治疗新型冠状病毒肺炎后的缓慢性心律失常：文献综述及流行病学观察性研究的荟萃分析
Cardiol Res. 2022 Jun;13(3):135-143. doi: 10.14740/cr1377. Epub 2022 May 10.

引用本文的文献

1
Necrotizing Pancreatitis Following Acute Appendicitis: A Case Report of a Complex Clinical Course and Diagnostic Challenges.急性阑尾炎后坏死性胰腺炎：复杂临床病程及诊断挑战的病例报告
Cureus. 2025 Jan 16;17(1):e77556. doi: 10.7759/cureus.77556. eCollection 2025 Jan.
2
Is insulin resistance truly responsible for post-COVID depression?胰岛素抵抗真的是新冠后抑郁症的病因吗？
Braz J Psychiatry. 2023 May 1;45(4):379. doi: 10.47626/1516-4446-2023-3123.

本文引用的文献

1
Prevalence of self-medication during COVID-19 pandemic: A systematic review and meta-analysis.新冠大流行期间自我药疗的流行情况：系统评价和荟萃分析。
Front Public Health. 2022 Nov 3;10:1041695. doi: 10.3389/fpubh.2022.1041695. eCollection 2022.
2
Severe SARS-CoV-2 infection in a 32-week pregnant woman treated with Remdesivir-Dexamethasone combination therapy: A case report.一名32周孕妇接受瑞德西韦-地塞米松联合治疗的严重新型冠状病毒2型感染：病例报告
Clin Case Rep. 2022 Aug 11;10(8):e6241. doi: 10.1002/ccr3.6241. eCollection 2022 Aug.
3
Prevalence and Outcomes of Pancreatic Enzymes Elevation in Patients With COVID-19: A Meta-Analysis and Systematic Review.
新型冠状病毒肺炎患者胰腺酶升高的患病率及结局：一项荟萃分析和系统评价。
Front Public Health. 2022 May 12;10:865855. doi: 10.3389/fpubh.2022.865855. eCollection 2022.
4
Diagnosis and Management of Acute Appendicitis in Adults: A Review.成人急性阑尾炎的诊断与管理：综述
JAMA. 2021 Dec 14;326(22):2299-2311. doi: 10.1001/jama.2021.20502.
5
Pleural effusion volume in patients with acute pancreatitis: a retrospective study from three acute pancreatitis centers.急性胰腺炎患者胸腔积液量：来自三个急性胰腺炎中心的回顾性研究。
Ann Med. 2021 Dec;53(1):2003-2018. doi: 10.1080/07853890.2021.1998594.
6
Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.COVID-19 患者胸腔积液的患病率和临床结局：系统评价和荟萃分析。
J Med Virol. 2022 Jan;94(1):229-239. doi: 10.1002/jmv.27301. Epub 2021 Sep 1.
7
Association between acute pancreatitis and COVID-19 infection: What do we know?急性胰腺炎与新型冠状病毒肺炎感染之间的关联：我们了解些什么？
World J Gastrointest Surg. 2021 Jun 27;13(6):548-562. doi: 10.4240/wjgs.v13.i6.548.
8
Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.瑞德西韦致新型冠状病毒肺炎患者心动过缓：一项单中心前瞻性研究
Circ Arrhythm Electrophysiol. 2021 Jul;14(7):e009811. doi: 10.1161/CIRCEP.121.009811. Epub 2021 Jun 29.
9
An effect of the COVID-19 pandemic: Significantly more complicated appendicitis due to delayed presentation of patients!新冠疫情的影响：由于患者就诊延迟，导致阑尾炎明显更为复杂！
PLoS One. 2021 May 25;16(5):e0249171. doi: 10.1371/journal.pone.0249171. eCollection 2021.
10
Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.一名59岁男性在接受瑞德西韦治疗新型冠状病毒肺炎时出现心动过缓。
CMAJ. 2021 Apr 26;193(17):E612-E615. doi: 10.1503/cmaj.210300.